Prognostic significance of BCL-2 expression in triple negative breast cancer (TNBC)

被引：0
|
作者：
Srinivasalu, V. K. [1 ,2 ]
Susan, A. [3 ]
Jose, W. M. [4 ]
Philip, A. [5 ]
Nambiar, A. [6 ]
Pavithran, K. [5 ]
机构：
[1] Mazumdar Shaw Canc Ctr, Med Oncol & Hematol, Bangalore, Karnataka, India
[2] Narayana Hrudayalaya, Bangalore, Karnataka, India
[3] Lakeshore Hosp, Med Oncol, Kochi, Kerala, India
[4] Amrita Inst Med Sci, Inst Canc, Med Oncol & Hematol, Kochi, Kerala, India
[5] Amrita Inst Med Sci, Med Oncol, Kochi, Kerala, India
[6] Amrita Inst Med Sci, Pathol, Kochi, Kerala, India
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical significance of BCL-2 with basal and non-basal triple negative breast cancer (TNBC)
    Srinivasalu, V. K.
    Susan, A.
    Philip, A.
    Jose, W. M.
    Nambiar, A.
    Pavithran, K.
    ANNALS OF ONCOLOGY, 2019, 30 : 46 - 46
  • [2] Bcl-2 antigen expression in luminal A and triple-negative breast cancer
    Escorcio-Dourado, Carla Solange
    Martins, Luana Mota
    Simplicio-Revoredo, Camila Maria
    Sampaio, Fabiane Araujo
    Tavares, Cleciton Braga
    da Silva-Sampaio, Joao Paulo
    Borges, Umbelina Soares
    Alves-Ribeiro, Francisco Adelton
    Lopes-Costa, Pedro Vitor
    Lima-Dourado, Jose Charles
    da Silva, Benedito Borges
    MEDICAL ONCOLOGY, 2017, 34 (09)
  • [3] Bcl-2 antigen expression in luminal A and triple-negative breast cancer
    Carla Solange Escórcio-Dourado
    Luana Mota Martins
    Camila Maria Simplício-Revoredo
    Fabiane Araújo Sampaio
    Cléciton Braga Tavares
    João Paulo da Silva-Sampaio
    Umbelina Soares Borges
    Francisco Adelton Alves-Ribeiro
    Pedro Vitor Lopes-Costa
    José Charles Lima-Dourado
    Benedito Borges da Silva
    Medical Oncology, 2017, 34
  • [4] Bcl-2 expression and triple negative profile in breast carcinoma
    Kallel-Bayoudh, Imen
    Ben Hassen, Hanen
    Khabir, Abdelmajid
    Boujelbene, Noureddine
    Daoud, Jamel
    Frikha, Mounir
    Sallemi-Boudawara, Tahia
    Aifa, Sami
    Rebai, Ahmed
    MEDICAL ONCOLOGY, 2011, 28 : S55 - S61
  • [5] Bcl-2 expression and triple negative profile in breast carcinoma
    Imen Kallel-Bayoudh
    Hanen Ben Hassen
    Abdelmajid Khabir
    Noureddine Boujelbene
    Jamel Daoud
    Mounir Frikha
    Tahia Sallemi-Boudawara
    Sami Aifa
    Ahmed Rebaï
    Medical Oncology, 2011, 28 : 55 - 61
  • [6] Different Prognostic Factors Correlate with Bcl-2 Expression among Triple Negative and Non-Triple Negative Breast Cancers
    Abd El-Mageed, Amal Abd El-Hafez
    Mohamed, Abd El-aty Shawky
    Elesawy, Basem Hasan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 1037 - 1041
  • [7] Biomarkers Expression in Triple Negative Breast Cancer (TNBC)
    Nofech-Mozes, Sharon
    Han, Rachel
    Olkhov-Mitsel, Ekaterina
    Lu, Fang-I
    Plotkin, Anna
    Hanna, Wedad
    Slodkowska, Elzbieta
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 135 - 137
  • [8] Biomarkers Expression in Triple Negative Breast Cancer (TNBC)
    Nofech-Mozes, Sharon
    Han, Rachel
    Olkhov-Mitsel, Ekaterina
    Lu, Fang-I
    Plotkin, Anna
    Hanna, Wedad
    Slodkowska, Elzbieta
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 135 - 137
  • [9] Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy
    Choi, Jung Eun
    Kang, Su Hwan
    Lee, Soo Jung
    Bae, Young Kyung
    TUMOR BIOLOGY, 2014, 35 (12) : 12255 - 12263
  • [10] Filamin-A expression in triple negative breast cancer (TNBC) and its clinical significance
    Ouban, A.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S43 - S43
12345